ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Douglas E. Wood
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wood, D. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wood, D. E.

Ann Thorac Surg 2003;75:1751
© 2003 The Society of Thoracic Surgeons

Original article: general thoracic

Invited commentary

Douglas E. Wood, MDa

a Division of Thoracic Surgery, University of Washington, 1959 NE Pacific, AA-115, Seattle, WA 98195-6310, USA

e-mail: dewood@u.washington.edu

The first 20% of the full text of this article appears below.

Doctor Osaki and colleagues have provided us with their large and well-analyzed experience of surgical resection for T4 nonsmall cell lung cancer. They have nicely identified the key point that we all try to communicate to our pulmonary medicine, medical and radiation oncology colleagues—that not all stage IIIB lung cancer is the same, and that selected patients may still benefit from surgical resection. It is certainly clear from the literature and from this paper that T4N0-1 disease is biologically different than the N3 disease that makes up the majority of stage . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 by The Society of Thoracic Surgeons.